262 related articles for article (PubMed ID: 9371566)
1. Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers.
Zheng ZM; He PJ; Baker CC
J Virol; 1997 Dec; 71(12):9096-107. PubMed ID: 9371566
[TBL] [Abstract][Full Text] [Related]
2. Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor.
Zheng ZM; He P; Baker CC
J Virol; 1996 Jul; 70(7):4691-9. PubMed ID: 8676495
[TBL] [Abstract][Full Text] [Related]
3. Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo.
Zheng ZM; Quintero J; Reid ES; Gocke C; Baker CC
J Virol; 2000 Jul; 74(13):5902-10. PubMed ID: 10846071
[TBL] [Abstract][Full Text] [Related]
4. Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3' splice site.
Zheng ZM; He PJ; Baker CC
J Virol; 1999 Jan; 73(1):29-36. PubMed ID: 9847303
[TBL] [Abstract][Full Text] [Related]
5. Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.
Zheng ZM; Reid ES; Baker CC
J Virol; 2000 Nov; 74(22):10612-22. PubMed ID: 11044105
[TBL] [Abstract][Full Text] [Related]
6. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
Liu X; Mayeda A; Tao M; Zheng ZM
J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
[TBL] [Abstract][Full Text] [Related]
7. A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.
Zheng ZM; Huynen M; Baker CC
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14088-93. PubMed ID: 9826658
[TBL] [Abstract][Full Text] [Related]
8. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
9. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer.
Ramchatesingh J; Zahler AM; Neugebauer KM; Roth MB; Cooper TA
Mol Cell Biol; 1995 Sep; 15(9):4898-907. PubMed ID: 7651409
[TBL] [Abstract][Full Text] [Related]
10. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
[TBL] [Abstract][Full Text] [Related]
11. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
[TBL] [Abstract][Full Text] [Related]
12. Exonic splicing enhancers contribute to the use of both 3' and 5' splice site usage of rat beta-tropomyosin pre-mRNA.
Selvakumar M; Helfman DM
RNA; 1999 Mar; 5(3):378-94. PubMed ID: 10094307
[TBL] [Abstract][Full Text] [Related]
13. SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element.
McNally LM; McNally MT
J Virol; 1996 Feb; 70(2):1163-72. PubMed ID: 8551577
[TBL] [Abstract][Full Text] [Related]
14. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences.
Schaal TD; Maniatis T
Mol Cell Biol; 1999 Mar; 19(3):1705-19. PubMed ID: 10022858
[TBL] [Abstract][Full Text] [Related]
15. Specific binding of an exonic splicing enhancer by the pre-mRNA splicing factor SRp55.
Nagel RJ; Lancaster AM; Zahler AM
RNA; 1998 Jan; 4(1):11-23. PubMed ID: 9436904
[TBL] [Abstract][Full Text] [Related]
16. Parameters that affect in vitro splicing of bovine papillomavirus type 1 late pre-mRNAs.
Zheng ZM; Baker CC
J Virol Methods; 2000 Mar; 85(1-2):203-14. PubMed ID: 10716353
[TBL] [Abstract][Full Text] [Related]
17. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
[TBL] [Abstract][Full Text] [Related]
18. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
[TBL] [Abstract][Full Text] [Related]
19. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
Shih SR; Krug RM
EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
[TBL] [Abstract][Full Text] [Related]
20. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
Li X; Shambaugh ME; Rottman FM; Bokar JA
RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
